Senzar Asset Management as of Dec. 31, 2014
Portfolio Holdings for Senzar Asset Management
Senzar Asset Management holds 32 positions in its portfolio as reported in the December 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Sanofi-Aventis SA (SNY) | 9.4 | $32M | 705k | 45.61 | |
| Mylan | 7.7 | $26M | 463k | 56.37 | |
| Community Health Systems (CYH) | 6.9 | $24M | 435k | 53.92 | |
| Valeant Pharmaceuticals Int | 6.3 | $22M | 150k | 143.11 | |
| Actavis | 5.4 | $18M | 72k | 257.42 | |
| Teva Pharmaceutical Industries (TEVA) | 3.9 | $13M | 231k | 57.51 | |
| Biogen Idec (BIIB) | 3.8 | $13M | 38k | 339.44 | |
| Magellan Health Services | 3.7 | $13M | 209k | 60.03 | |
| Ironwood Pharmaceuticals (IRWD) | 3.5 | $12M | 782k | 15.32 | |
| Concert Pharmaceuticals I equity | 3.4 | $12M | 866k | 13.32 | |
| CONMED Corporation (CNMD) | 3.3 | $11M | 249k | 44.96 | |
| Covidien | 3.2 | $11M | 106k | 102.28 | |
| Insmed (INSM) | 3.1 | $11M | 678k | 15.47 | |
| Salix Pharmaceuticals | 2.9 | $9.8M | 85k | 114.94 | |
| Intercept Pharmaceuticals In | 2.8 | $9.7M | 62k | 155.99 | |
| XenoPort | 2.8 | $9.5M | 1.1M | 8.77 | |
| Orthofix International Nv Com Stk | 2.7 | $9.2M | 307k | 30.06 | |
| Five Prime Therapeutics | 2.6 | $9.0M | 333k | 27.00 | |
| Nevro (NVRO) | 2.4 | $8.2M | 213k | 38.67 | |
| Medivation | 2.3 | $7.9M | 80k | 99.61 | |
| Retrophin | 2.3 | $7.8M | 636k | 12.24 | |
| Repros Therapeutics | 2.2 | $7.6M | 764k | 9.97 | |
| Momenta Pharmaceuticals | 2.1 | $7.0M | 584k | 12.04 | |
| Sagent Pharmaceuticals | 2.0 | $6.7M | 268k | 25.11 | |
| Corium Intl | 1.8 | $6.2M | 1.0M | 6.10 | |
| Acelrx Pharmaceuticals | 1.8 | $6.1M | 907k | 6.73 | |
| Rigel Pharmaceuticals | 1.4 | $4.8M | 2.1M | 2.27 | |
| Foamix Pharmaceuticals | 1.1 | $3.6M | 513k | 7.01 | |
| Bluebird Bio (BLUE) | 1.0 | $3.5M | 38k | 91.72 | |
| Biota Pharmaceuticals | 0.9 | $3.2M | 1.4M | 2.24 | |
| Syneron Medical Ltd ord | 0.8 | $2.8M | 301k | 9.33 | |
| Enanta Pharmaceuticals (ENTA) | 0.7 | $2.2M | 44k | 50.84 |
